APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non Corticosteroid Anti-inflammatory Eyedrops

Compare research editions
View pricing & licenses

Selected research

Industry Research

Non Corticosteroid Anti-inflammatory Eyedrops Industry Research Report 2026

19 December 2025130 pages

Choose your research edition.

Industry ResearchNon Corticosteroid Anti-inflammatory Eyedrops Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Corticosteroid Anti-inflammatory Eyedrops Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non Corticosteroid Anti-inflammatory Eyedrops market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Non Corticosteroid Anti-inflammatory Eyedrops is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops include Novartis AG, Allergan, Inc., Walgreens, Viva Opti-Free, Visine, Systane, Staples, Similasan Corporation and Rite Aid, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Non Corticosteroid Anti-inflammatory Eyedrops market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Non Corticosteroid Anti-inflammatory Eyedrops Market by Company

Novartis AG

Allergan, Inc.

Walgreens

Viva Opti-Free

Visine

Systane

Staples

Similasan Corporation

Rite Aid

Meda Pharmaceuticals Inc

Clear eyes

Cigna

Bausch & Lomb Inc

Bausch & Lomb

Alcon

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Type

Diclofenac

Mugabe

Ocufen

Others

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Application

Adult

Children

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Corticosteroid Anti-inflammatory Eyedrops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Corticosteroid Anti-inflammatory Eyedrops and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Corticosteroid Anti-inflammatory Eyedrops.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Non Corticosteroid Anti-inflammatory Eyedrops manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Non Corticosteroid Anti-inflammatory Eyedrops by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Non Corticosteroid Anti-inflammatory Eyedrops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Manufacturers (2021-2026) Table 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue of Manufacturers (2021-2026) Table 9. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Non Corticosteroid Anti-inflammatory Eyedrops Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Product Type & Application Table 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Non Corticosteroid Anti-inflammatory Eyedrops by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Novartis AG Company Information Table 19. Novartis AG Business Overview Table 20. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 22. Novartis AG Recent Developments Table 23. Allergan, Inc. Company Information Table 24. Allergan, Inc. Business Overview Table 25. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 27. Allergan, Inc. Recent Developments Table 28. Walgreens Company Information Table 29. Walgreens Business Overview Table 30. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 32. Walgreens Recent Developments Table 33. Viva Opti-Free Company Information Table 34. Viva Opti-Free Business Overview Table 35. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 37. Viva Opti-Free Recent Developments Table 38. Visine Company Information Table 39. Visine Business Overview Table 40. Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 42. Visine Recent Developments Table 43. Systane Company Information Table 44. Systane Business Overview Table 45. Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 47. Systane Recent Developments Table 48. Staples Company Information Table 49. Staples Business Overview Table 50. Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 52. Staples Recent Developments Table 53. Similasan Corporation Company Information Table 54. Similasan Corporation Business Overview Table 55. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 57. Similasan Corporation Recent Developments Table 58. Rite Aid Company Information Table 59. Rite Aid Business Overview Table 60. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 62. Rite Aid Recent Developments Table 63. Meda Pharmaceuticals Inc Company Information Table 64. Meda Pharmaceuticals Inc Business Overview Table 65. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 67. Meda Pharmaceuticals Inc Recent Developments Table 68. Clear eyes Company Information Table 69. Clear eyes Business Overview Table 70. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 72. Clear eyes Recent Developments Table 73. Cigna Company Information Table 74. Cigna Business Overview Table 75. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 77. Cigna Recent Developments Table 78. Bausch & Lomb Inc Company Information Table 79. Bausch & Lomb Inc Business Overview Table 80. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 82. Bausch & Lomb Inc Recent Developments Table 83. Bausch & Lomb Company Information Table 84. Bausch & Lomb Business Overview Table 85. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 87. Bausch & Lomb Recent Developments Table 88. Alcon Company Information Table 89. Alcon Business Overview Table 90. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 92. Alcon Recent Developments Table 93. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2021-2026) & (W Units) Table 95. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2021-2026) Table 96. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2027-2032) & (W Units) Table 97. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2027-2032) Table 98. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2021-2026) Table 100. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2027-2032) Table 102. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 104. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2027-2032) & (W Units) Table 105. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 109. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2027-2032) & (W Units) Table 110. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 114. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2027-2032) & (W Units) Table 115. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 119. South America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2027-2032) & (W Units) Table 120. South America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 124. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2027-2032) & (W Units) Table 125. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (W Units) Table 128. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2027-2032) & (W Units) Table 129. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2021-2026) Table 130. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2027-2032) Table 131. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2021-2026) Table 134. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2027-2032) Table 135. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2021-2026) & (US$/Unit) Table 136. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2027-2032) & (US$/Unit) Table 137. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (W Units) Table 138. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2027-2032) & (W Units) Table 139. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2021-2026) Table 140. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2027-2032) Table 141. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2021-2026) Table 144. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2027-2032) Table 145. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2021-2026) & (US$/Unit) Table 146. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Non Corticosteroid Anti-inflammatory Eyedrops Distributors List Table 150. Non Corticosteroid Anti-inflammatory Eyedrops Customers List Table 151. Non Corticosteroid Anti-inflammatory Eyedrops Industry Trends Table 152. Non Corticosteroid Anti-inflammatory Eyedrops Industry Drivers Table 153. Non Corticosteroid Anti-inflammatory Eyedrops Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Non Corticosteroid Anti-inflammatory Eyedrops Product Image Figure 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size (2021-2032) & (US$ Million) Figure 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (2021-2032) & (W Units) Figure 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Average Price (US$/Unit) & (2021-2032) Figure 9. Diclofenac Product Image Figure 10. Mugabe Product Image Figure 11. Ocufen Product Image Figure 12. Others Product Image Figure 13. Adult Product Image Figure 14. Children Product Image Figure 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Non Corticosteroid Anti-inflammatory Eyedrops Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region in 2025 Figure 21. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region in 2025 Figure 22. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country in 2025 Figure 23. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2032) Figure 24. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2021-2032) Figure 25. United States Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country in 2025 Figure 28. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2032) Figure 29. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2021-2032) Figure 30. Germany Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country in 2025 Figure 37. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2021-2032) Figure 39. China Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country in 2025 Figure 48. South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2032) Figure 49. South America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2021-2032) Figure 50. Mexico Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country in 2025 Figure 54. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2021-2032) Figure 56. Turkey Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2021-2032) Figure 60. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2021-2032) Figure 61. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (US$/Unit) by Type (2021-2032) Figure 62. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2021-2032) Figure 63. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2021-2032) Figure 64. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (US$/Unit) by Application (2021-2032) Figure 65. Non Corticosteroid Anti-inflammatory Eyedrops Value Chain Figure 66. Non Corticosteroid Anti-inflammatory Eyedrops Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Non Corticosteroid Anti-inflammatory Eyedrops Industry Opportunities and Challenges

Scope & coverage.

Types
  • Diclofenac
  • Mugabe
  • Ocufen
  • Others
Applications
  • Adult
  • Children
Companies covered
  • Novartis AG
  • Allergan, Inc.
  • Walgreens
  • Viva Opti-Free
  • Visine
  • Systane
  • Staples
  • Similasan Corporation
  • Rite Aid
  • Meda Pharmaceuticals Inc
  • Clear eyes
  • Cigna
  • Bausch & Lomb Inc
  • Bausch & Lomb
  • Alcon

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size (2021-2032)
  4. 2.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (2021-2032)
  5. 2.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Average Price (2021-2032)
  6. 2.3 Non Corticosteroid Anti-inflammatory Eyedrops by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Diclofenac
  9. 2.3.3 Mugabe
  10. 2.3.4 Ocufen
  11. 2.3.5 Others
  12. 2.4 Non Corticosteroid Anti-inflammatory Eyedrops by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Adult
  15. 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Non Corticosteroid Anti-inflammatory Eyedrops Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Product Type & Application
  8. 3.8 Global Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Established Date
  9. 3.9 Global Non Corticosteroid Anti-inflammatory Eyedrops Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Novartis AG
  2. 4.1.1 Novartis AG Company Information
  3. 4.1.2 Novartis AG Business Overview
  4. 4.1.3 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  6. 4.1.5 Novartis AG Recent Developments
  7. 4.2 Allergan, Inc.
  8. 4.2.1 Allergan, Inc. Company Information
  9. 4.2.2 Allergan, Inc. Business Overview
  10. 4.2.3 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  12. 4.2.5 Allergan, Inc. Recent Developments
  13. 4.3 Walgreens
  14. 4.3.1 Walgreens Company Information
  15. 4.3.2 Walgreens Business Overview
  16. 4.3.3 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  18. 4.3.5 Walgreens Recent Developments
  19. 4.4 Viva Opti-Free
  20. 4.4.1 Viva Opti-Free Company Information
  21. 4.4.2 Viva Opti-Free Business Overview
  22. 4.4.3 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  24. 4.4.5 Viva Opti-Free Recent Developments
  25. 4.5 Visine
  26. 4.5.1 Visine Company Information
  27. 4.5.2 Visine Business Overview
  28. 4.5.3 Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  30. 4.5.5 Visine Recent Developments
  31. 4.6 Systane
  32. 4.6.1 Systane Company Information
  33. 4.6.2 Systane Business Overview
  34. 4.6.3 Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  36. 4.6.5 Systane Recent Developments
  37. 4.7 Staples
  38. 4.7.1 Staples Company Information
  39. 4.7.2 Staples Business Overview
  40. 4.7.3 Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  42. 4.7.5 Staples Recent Developments
  43. 4.8 Similasan Corporation
  44. 4.8.1 Similasan Corporation Company Information
  45. 4.8.2 Similasan Corporation Business Overview
  46. 4.8.3 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  48. 4.8.5 Similasan Corporation Recent Developments
  49. 4.9 Rite Aid
  50. 4.9.1 Rite Aid Company Information
  51. 4.9.2 Rite Aid Business Overview
  52. 4.9.3 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  54. 4.9.5 Rite Aid Recent Developments
  55. 4.10 Meda Pharmaceuticals Inc
  56. 4.10.1 Meda Pharmaceuticals Inc Company Information
  57. 4.10.2 Meda Pharmaceuticals Inc Business Overview
  58. 4.10.3 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  60. 4.10.5 Meda Pharmaceuticals Inc Recent Developments
  61. 4.11 Clear eyes
  62. 4.11.1 Clear eyes Company Information
  63. 4.11.2 Clear eyes Business Overview
  64. 4.11.3 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  66. 4.11.5 Clear eyes Recent Developments
  67. 4.12 Cigna
  68. 4.12.1 Cigna Company Information
  69. 4.12.2 Cigna Business Overview
  70. 4.12.3 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  72. 4.12.5 Cigna Recent Developments
  73. 4.13 Bausch & Lomb Inc
  74. 4.13.1 Bausch & Lomb Inc Company Information
  75. 4.13.2 Bausch & Lomb Inc Business Overview
  76. 4.13.3 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  78. 4.13.5 Bausch & Lomb Inc Recent Developments
  79. 4.14 Bausch & Lomb
  80. 4.14.1 Bausch & Lomb Company Information
  81. 4.14.2 Bausch & Lomb Business Overview
  82. 4.14.3 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  84. 4.14.5 Bausch & Lomb Recent Developments
  85. 4.15 Alcon
  86. 4.15.1 Alcon Company Information
  87. 4.15.2 Alcon Business Overview
  88. 4.15.3 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  90. 4.15.5 Alcon Recent Developments
5 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Scenario by Region
  1. 5.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region: 2021-2032
  3. 5.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region: 2021-2026
  4. 5.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region: 2027-2032
  5. 5.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region: 2021-2032
  6. 5.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region: 2021-2026
  7. 5.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region: 2027-2032
  8. 5.4 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures by Country
  9. 5.4.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2032)
  11. 5.4.3 North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures by Country
  15. 5.5.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2032)
  17. 5.5.3 Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures by Country
  36. 5.7.1 South America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2032)
  38. 5.7.3 South America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2032)
  2. 6.1.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2021-2032)
  4. 6.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2021-2032)
  5. 6.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2032)
  2. 7.1.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2021-2032)
  4. 7.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2021-2032)
  5. 7.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Non Corticosteroid Anti-inflammatory Eyedrops Value Chain Analysis
  2. 8.1.1 Non Corticosteroid Anti-inflammatory Eyedrops Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Non Corticosteroid Anti-inflammatory Eyedrops Production Mode & Process
  5. 8.2 Non Corticosteroid Anti-inflammatory Eyedrops Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Non Corticosteroid Anti-inflammatory Eyedrops Distributors
  8. 8.2.3 Non Corticosteroid Anti-inflammatory Eyedrops Customers
9 Global Non Corticosteroid Anti-inflammatory Eyedrops Analyzing Market Dynamics
  1. 9.1 Non Corticosteroid Anti-inflammatory Eyedrops Industry Trends
  2. 9.2 Non Corticosteroid Anti-inflammatory Eyedrops Industry Drivers
  3. 9.3 Non Corticosteroid Anti-inflammatory Eyedrops Industry Opportunities and Challenges
  4. 9.4 Non Corticosteroid Anti-inflammatory Eyedrops Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst